U.S. Drug Enforcement Administration agents have begun investigating telehealth provider Done Global Inc.’s practices for prescribing controlled substances, reports Fierce Healthcare. Done is a membership-based platform that connects patients seeking treatment for attention-deficit hyperactivity disorder with qualified clinicians. Federal authorities are increasingly scrutinizing telehealth companies that prescribe stimulants like Adderall for treatment of ADHD.
Texas Blues faces $900 million hospital demand in contract dispute
